Prime mover or fellow traveller: 25-hydroxy vitamin D's seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC).

Authors:
Hugh Tunstall-Pedoe
Hugh Tunstall-Pedoe
University of Dundee
United Kingdom
Mark Woodward
Mark Woodward
The George Institute for Global Health
Australia
Maria Hughes
Maria Hughes
Queensland Institute of Medical Research
Australia
Annie Anderson
Annie Anderson
University of Dundee
United Kingdom

Int J Epidemiol 2015 Oct 21;44(5):1602-12. Epub 2015 Jun 21.

National Institute for Health and Welfare, Helsinki, Finland.

Background: Theoretical links between seasonal lack of sunlight, hypovitaminosis D and excess cardiovascular disease and death prompted our adding novel to conventional cohort analyses.

Methods: We tested three postulates on 13,224 Scottish Heart Health Extended Cohort participants, assayed for 25-hydroxyvitamin D (25OHD) and followed for 22 years. (i) Endpoints enumerated by month of occurrence mirror annual seasonal oscillation in 25OHD. (ii) Endpoint seasonality is increased in people with below median 25OHD. (iii) Low 25OHD predicts endpoints independently of major risk factors.

Results: Baseline median 25OHD level was 36.4 (other quartiles 26.7, 51.7) nmol/l. The March trough was half the August peak, both well after seasonal solstices. (i) There was no demonstrable monthly variation in First Cardiovascular Event (n = 3307). Peaks and troughs for All Death and Cardiovascular Death (n = 2987, 1350) were near the solstices, earlier than extremes of 25OHD. (ii) Endpoint variability showed no difference between those above and below median 25OHD. (iii) Cox model hazard ratios (HR), by decreasing 25OHD, increased modestly and nonspecifically for all endpoints examined, with no threshold, the gradients diminishing by ∼ : 60% following multiple adjustment. For Cardiovascular Disease, HR, by 20 (∼ SD) nmol/l decrease, =1.224 (1.175, 1.275) adjusted for age and sex; additionally adjusted for family history, deprivation index, smoking, systolic blood pressure, total and HDL cholesterol, =1.093 (1.048, 1.139); All Deaths = 1.238 (1.048, 1.139) and 1.098 (1.050, 1.149). 25OHD made no independent contribution to cardiovascular discrimination and reclassification.

Conclusions: Our analyses challenge vitamin D's alleged role as major prime mover in cardiovascular disease and mortality.

Download full-text PDF

Source
http://dx.doi.org/10.1093/ije/dyv092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681106PMC
October 2015
19 Reads

Publication Analysis

Top Keywords

cardiovascular disease
16
median 25ohd
12
25ohd
9
disease death
8
variation cardiovascular
8
scottish heart
8
25ohd endpoint
8
1048 1139
8
health extended
8
heart health
8
vitamin d's
8
extended cohort
8
25ohd iii
8
prime mover
8
cardiovascular
7
earlier extremes
4
extremes 25ohd
4
variability difference
4
endpoint variability
4
solstices earlier
4

Similar Publications

Prime mover or fellow traveller: 25 hydroxyvitamin D's seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC).

Int J Epidemiol 2016 Feb 20;45(1):289-90. Epub 2016 Jan 20.

Cardiovascular Epidemiology Unit, Institute of Cardiovascular Research, Ninewells Hospital and Medical School, University of Dundee, Scotland DD1 9SY.

View Article
February 2016

Plasma 25-Hydroxyvitamin D and Mortality in Patients With Suspected Stable Angina Pectoris.

J Clin Endocrinol Metab 2018 03;103(3):1161-1170

Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Context And Objective: Vitamin D status may affect cardiovascular disease (CVD) development and survival. We studied the relationship between concentrations of the circulating biomarker 25-hydroxyvitamin D (25OHD) and all-cause and cardiovascular mortality risk.

Design, Setting, Participants, And Main Outcome Measures: 25OHD, the sum of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2, was analyzed in plasma samples from 4114 white patients suspected of having stable angina pectoris and was adjusted for seasonal variation. Read More

View Article
March 2018

Cosinor modelling of seasonal variation in 25-hydroxyvitamin D concentrations in cardiovascular patients in Norway.

Eur J Clin Nutr 2016 Apr 25;70(4):517-22. Epub 2015 Nov 25.

Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Background/objectives: Seasonal variation may reduce the validity of 25-hydroxyvitamin D (25OHD) as a biomarker of vitamin D status. Here we aimed to identify potential determinants of seasonal variation in 25OHD concentrations and to evaluate cosinor modelling as a method to adjust single 25OHD measurements for seasonal variation.

Subjects/methods: In Caucasian cardiovascular patients (1999-2004), we measured 25OHD by liquid chromatography tandem mass spectrometry in 4116 baseline and 528 follow-up samples. Read More

View Article
April 2016

Circulating 25OHD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: the MIDSPAN Family Study.

J Clin Endocrinol Metab 2012 Dec 15;97(12):4578-87. Epub 2012 Oct 15.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, United Kingdom.

Context: Observational studies relating circulating 25-hydroxyvitamin D (25OHD) and dietary vitamin D intake to cardiovascular disease (CVD) have reported conflicting results.

Objective: Our objective was to investigate the association of 25OHD, dietary vitamin D, PTH, and adjusted calcium with CVD and mortality in a Scottish cohort.

Design And Setting: The MIDSPAN Family Study is a prospective study of 1040 men and 1298 women from the West of Scotland recruited in 1996 and followed up for a median 14. Read More

View Article
December 2012